Cargando…

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers

Capsule-based dry powder inhalers (cDPIs) are widely utilized in the delivery of pharmaceutical powders to the lungs. In these systems, the fundamental nature of the interactions between the drug/formulation powder, the capsules, the inhaler device, and the patient must be fully elucidated in order...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Li, Brunaugh, Ashlee D., Stegemann, Sven, Jermain, Scott V., Herpin, Matthew J., Kalafat, Justin, Smyth, Hugh D. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399055/ https://www.ncbi.nlm.nih.gov/pubmed/34452174 http://dx.doi.org/10.3390/pharmaceutics13081213

Ejemplares similares

Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations
por: Ding, Li, et al.
Publicado: (2022)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
por: Brunaugh, Ashlee D., et al.
Publicado: (2021)

Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Erratum to: Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization
por: Groß, Roman, et al.
Publicado: (2022)

Ease-of-use preference for the ELLIPTA(®) dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
por: Komase, Yuko, et al.
Publicado: (2014)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
por: Mohan, Abhinav Ram, et al.
Publicado: (2022)

Performance of Dry Powder Inhalers with Single Dosed Capsules in Preschool Children and Adults Using Improved Upper Airway Models
por: Lindert, Sandra, et al.
Publicado: (2014)

Allyl isothiocyanate dry powder inhaler based on cyclodextrin-metal organic frameworks for pulmonary delivery
por: Sun, Nianxia, et al.
Publicado: (2022)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022)

Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
por: Allan, Richard, et al.
Publicado: (2021)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Feedback systems in multi-dose dry powder inhalers
por: Emeryk, Andrzej, et al.
Publicado: (2022)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023)

Effect of compression pressure on inhalation grade lactose as carrier for dry powder inhalations
por: Raut, Neha Sureshrao, et al.
Publicado: (2016)

Appropriate use of a dry powder inhaler based on inhalation flow pattern
por: Kondo, Tetsuri, et al.
Publicado: (2017)

A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy
por: Dal Negro, Roberto Walter, et al.
Publicado: (2021)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
por: Marante, Tânia, et al.
Publicado: (2020)

Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers
por: Zhang, Tongtong, et al.
Publicado: (2018)

In vitro dose comparison of Respimat(®) inhaler with dry powder inhalers for COPD maintenance therapy
por: Ciciliani, Anna-Maria, et al.
Publicado: (2017)

Influence of physical properties of carrier on the performance of dry powder inhalers
por: Peng, Tingting, et al.
Publicado: (2016)

Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering
por: Mehta, Piyush
Publicado: (2018)

Prerequisites for a dry powder inhaler for children with cystic fibrosis
por: Lexmond, Anne J., et al.
Publicado: (2017)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters
por: Sahakijpijarn, Sawittree, et al.
Publicado: (2021)

Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
por: Adhikari, Bishal Raj, et al.
Publicado: (2022)

Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
por: Liang, Di, et al.
Publicado: (2023)

Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer
por: Singh, D. J., et al.
Publicado: (2012)

Inhalable dry powder mRNA vaccines based on extracellular vesicles
por: Popowski, Kristen D., et al.
Publicado: (2022)

Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying
por: Okuda, Tomoyuki, et al.
Publicado: (2015)

Screening of Cyclodextrins in the Processing of Buserelin Dry Powders for Inhalation Prepared by Spray Freeze-Drying
por: Rostamnezhad, Mostafa, et al.
Publicado: (2023)

Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
por: Buttini, Francesca, et al.
Publicado: (2015)

Spray-Dried Inhalable Powder Formulations of Gentamicin Designed for Pneumonic Plague Therapy in a Mouse Model
por: Zhu, Menghuan, et al.
Publicado: (2022)

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hac6kmua17b6e4tl22vtafddgk